Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Barclays Maintains Underweight on Phibro Animal Health, Lowers Price Target to $17

Barclays analyst Balaji Prasad maintains Phibro Animal Health (NASDAQ:PAHC) with a Underweight and lowers the price target from $22 to $17.
byBenzinga Newsdesk
September 16, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Barclays analyst Balaji Prasad maintains Phibro Animal Health (NASDAQ:PAHC) with a Underweight and lowers the price target from $22 to $17.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts